Author

Carrie Lenneman, MD, MSCI ’10 discusses heart-healthy diet tips with CBS 42

Mar. 8, 2021—

Amit Rakhit, MD, MSCI ’02 provides update on Ovid Therapeutics’ ongoing efforts to develop treatments for Angelman syndrome

Mar. 5, 2021—

Ashley Shoemaker, MD, MSCI ’12 R01: Phase 2 Study of Theophylline for the Treatment of Pseudohypoparathyroidism

Mar. 5, 2021—

Jennifer Schuster, MD, MSCI ’14 discusses increase in number and severity of multisystem inflammatory syndrome (MIS-C) cases with Yahoo News and decrease of influenza cases with KSHB Kansas City News

Feb. 24, 2021—Cases of multisystem inflammatory syndrome in children are rising Yahoo!News Flu numbers far below normal during pandemic: Steep decline in positive tests during current flu season KSHB Kansas City News

New first-author study from Benson Hamooya, VIGH-UVP Fogarty Scholar, examines effects of antiretroviral therapy on HIV patients in Sub-Saharan Africa

Feb. 23, 2021—

Todd Rice, MD, MSCI ’05 and Jonathan Casey, MD, MSCI ’19 advance knowledge on COVID-19

Feb. 23, 2021—What it’s like to die from Covid-19 Meharry, Vanderbilt Clinical COVID-19 Trials Seek Local Participants New study to evaluate effectiveness of COVID-19 vaccines in preventing hospitalization Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients with COVID-19: A Randomized Clinical Trial

Satish Raj, MD, MSCI ’04 offers editorial discussing latest research on postural tachycardia syndrome in Journal of the American College of Cardiology

Feb. 19, 2021—

Pratik Pandharipande, MD, MSCI ’05 featured in VUMC Reporter story highlighting original research on ICU Sedatives published in NEJM

Feb. 5, 2021—

MSCI alumni, faculty, et al, study the effect of hydroxychloroquine in a randomized clinical trial in JAMA

Nov. 17, 2020—

**Andrew Masica, MD MSCI ’04 quoted in D Magazine’s “COVID-19 Is Redefining Healthcare Innovation”**

Nov. 3, 2020—